GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated June 24, 2025, reports transaction notifications for Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs). The filing covers transactions executed on June 19, 2025, on the London Stock Exchange.
Key Financial Metrics
The filing does not contain corporate financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively details specific share transactions involving company insiders.
Material Changes and Transaction Details
The filing discloses a series of coordinated transactions on June 19, 2025, involving Sally Jackson (SVP, Global Communications & CEO Office) and Dylan Jackson (PCA). The transactions facilitated the transfer of shares into an Individual Savings Account (ISA):
- Sally Jackson:
- Gifted 1,400 Ordinary Shares to a family member for nil consideration.
- Sold 1,395 Ordinary Shares at £14.3524 per share to facilitate an ISA transfer.
- Purchased 1,387 Ordinary Shares at £14.3378 per share into an ISA.
- Dylan Jackson:
- Sold 1,395 Ordinary Shares at £14.3524 per share to facilitate an ISA transfer.
- Purchased 1,385 Ordinary Shares at £14.3537 per share into an ISA.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of insider trading activity.
Investor Verification Points
- Verify the total net change in share ownership for Sally Jackson and Dylan Jackson following the gift, sale, and purchase transactions.
- Confirm the market price of GSK Ordinary Shares on June 19, 2025, to validate the transaction prices reported (approx. £14.33 - £14.35).
- Review the company's insider trading policy to ensure the timing and nature of these ISA transfers comply with internal blackout periods and pre-clearance requirements.